Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Leo Heunks and Harm Bogaard.
Leo Heunks
Connection Strength
0.415
Harm Bogaard
  1. Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial. Lancet Respir Med. 2021 09; 9(9):957-968.
    View in: PubMed
    Score: 0.238
  2. Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients. Front Immunol. 2021; 12:664209.
    View in: PubMed
    Score: 0.059
  3. Enrichment of CCR6+ CD8+ T cells and CCL20 in the lungs of mechanically ventilated patients with COVID-19. Eur J Immunol. 2021 06; 51(6):1535-1538.
    View in: PubMed
    Score: 0.059
  4. Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19. Thorax. 2021 10; 76(10):1010-1019.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.